How to Integrate Novel Treatment Classes for R/R Myeloma Into Clinical Practice: Information on BCMA-Targeted Therapies
In this podcast episode, Donna Catamero, ANP-BC, OCN, CCRC, highlights the key data and nursing considerations for integrating BCMA-targeted agents into the treatment plan for R/R MM, with a focus on belantamab mafodotin and idecabtagene vicleucel.